Robert T. Ishii

Partner at Wilson Sonsini Goodrich & Rosati PC

Robert T. Ishii

Robert T. Ishii

Partner at Wilson Sonsini Goodrich & Rosati PC

Biography

Partner
Mergers & Acquisitions

EXPERIENCE:

Robert Ishii is a partner in Wilson Sonsini Goodrich & Rosati's San Francisco office and is the leader of the firm's mergers and acquisitions group. His practice focuses on mergers and acquisitions, contests for corporate control, and other complex strategic transactions, including divestitures, joint ventures, and other transformative transactions.

Rob's extensive transactional experience includes more than 200 completed M&A transactions valued at over $150 billion. He has represented public and private companies, private equity funds, and financial advisors in negotiated and hostile transactions in the technology, medical technology, biotechnology, media, telecommunications, and other industries.

Rob is active in the management of the firm and the San Francisco office. He has served on the firm's Policy Committee, Nominating Committee, and Real Estate Committee.

SELECT TRANSACTIONS:
* Microchip in its $10.2 billion acquisition of Microsemi
* Lumentum in its $1.8 billion acquisition of Oclaro
* Pacific Biosciences in its $1.2 billion acquisition by Illumina
* Neotract in its acquisition by Teleflex for up to $1.1 billion
* Microchip in its $3.6 billion acquisition of Atmel, after the termination of its existing transaction with Dialog Semiconductor
* HomeAway in its $3.9 billion acquisition by Expedia
* Pharmacyclics in its $21 billion acquisition by AbbVie
* Stemcentrix' founder and principal stockholder in its $6 billion acquisition by AbbVie
* Apigee in its $625 million acquisition by Google
* Microchip Technology in its $840 million acquisition of Micrel
* Integrated Silicon Solution Inc. (ISSI) in its $800 million acquisition by a Chinese investment group led by SummitView Capital, after a public bidding war with Cypress Semiconductor
* Yodlee in its $660 million acquisition by Envestnet
* Technicolor in its $600 million acquisition of Cisco's Connected Device Division

* Seragon Pharmaceuticals in its acquisition by Roche for up to $1.7 billion
* Omnivision in its pending $1.9 billion acquisition by an investment group led by Hua Capital
* PneumRx in its acquisition by BTG for up to $475 million
* Aragon Pharmaceuticals in its acquisition by Johnson & Johnson for up to $1 billion, and in the related spinoff of Seragon Pharmaceuticals
* Verinata Health in its acquisition by Illumina for up to $450 million
* Wright Medical in its acquisition of Biomimetic for $380 million in cash, stock and contingent value rights
* Outdoor Channel in its $270 million acquisition by Kroenke Sports, after termination of its previously announced acquisition by Intermedia Partners
* SARcode Bioscience in its acquisition by Shire for up to $685 million
* Microchip Technology in its $940 million acquisition of Standard Microsystems Corp.
* Quanticel Pharmaceuticals in its strategic R&D collaboration with Celgene (including an option to acquire the company)
* Rambus in its $340 million acquisition of Cryptography Research
* Calistoga Pharmaceuticals in its acquisition by Gilead Sciences for up to $600 million
* Ardian in its acquisition by Medtronic for up to $1.5 billion
* Actel in its $590 million acquisition by Microsemi
* Microchip Technology in its $300 million acquisition of Silicon Storage Technology via unsolicited bid after a previously announced transaction
* Varian in its $1.5 billion acquisition by Agilent Technologies
* Acclarent in its $785 million acquisition by Ethicon (a Johnson & Johnson company)
* Logitech in its $405 million acquisition of Lifesize Communications
* Wind River Systems in its $900 million acquisition by Intel
* CoreValve in its $775 million acquisition by Medtronic
* Francisco Partners in $720 million sale of Metrologic Instruments
* Google in multiple acquisitions
* Twitter in multiple acquisitions
* More transactions
* Please see wsgr.com for a complete list of transactions.

EDUCATION:
* J.D., University of Chicago Law School
* A.B., Cornell University

HONORS:
* Recognized in the 2012-2018 editions of Northern California Super Lawyers
* Recognized as a "Life Science Star" in the finance and transactional section of LMG Life Sciences in 2013-2018
* Selected for inclusion in the 2016-2018 editions of Who's Who Legal: M&A

ADMISSIONS:
* State Bar of California
* State Bar of New York

Overview
RelSci Relationships

1554

Number of Boards

1

Number of Awards

3

Contact Data
Trying to get in touch with Robert T. Ishii? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Robert T. Ishii likely has professional access to. A relationship does not necessarily indicate a personal connection.

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Founding Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Senior & Founding Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Covington & Burling LLP

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

Partner at Wilson Sonsini Goodrich & Rosati PC

Relationship likelihood: Strong

In The News
The Deal Pipeline
November 6, 2013
M/A-COM gets Mindspeed
Paths to Robert T. Ishii
Potential Connections via
Relationship Science
You
Robert T. Ishii
Partner at Wilson Sonsini Goodrich & Rosati PC
Education
AB

Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, they have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes public engagement to help improve the quality of life in our state, the nation, the world.

JD

University of Chicago Law School is the graduate school of law at the University of Chicago. It was founded in 1902 by a coalition of donors led by John D. Rockefeller, and is consistently one of the highest-rated law schools in the United States. The U.S. News & World Report ranks it fourth among U.S. law schools, and it is noted particularly for its influence on the economic analysis of law.

Career History
Partner
2004 - Current

Wilson Sonsini Goodrich & Rosati PC is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past five decades, Wilson Sonsini Goodrich & Rosati has established its reputation by having an unmatched knowledge of its clients' industries and deep and long-standing contacts throughout the technology sector.The firm's legal expertise serves clients at all stages of growth, from venture-backed start-up companies to multibillion-dollar global enterprises. The firm's clients include some of the most recognized names in the technology, retail, life sciences, venture capital, and finance sectors.Their broad range of services and legal disciplines are focused on serving the principal challenges faced by management and the boards of directors of business enterprises. The firm is nationally recognized as a leader in corporate governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, joint ventures and strategic alliances, and technology licensing and other intellectual property transactions.The firm has offices in Austin, Georgetown, DE, Hong Kong, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai, and Washington, DC.

Boards & Committees
Member, Real Estate Committee
Prior

Wilson Sonsini Goodrich & Rosati PC is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past five decades, Wilson Sonsini Goodrich & Rosati has established its reputation by having an unmatched knowledge of its clients' industries and deep and long-standing contacts throughout the technology sector.The firm's legal expertise serves clients at all stages of growth, from venture-backed start-up companies to multibillion-dollar global enterprises. The firm's clients include some of the most recognized names in the technology, retail, life sciences, venture capital, and finance sectors.Their broad range of services and legal disciplines are focused on serving the principal challenges faced by management and the boards of directors of business enterprises. The firm is nationally recognized as a leader in corporate governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, joint ventures and strategic alliances, and technology licensing and other intellectual property transactions.The firm has offices in Austin, Georgetown, DE, Hong Kong, New York, Palo Alto, San Diego, San Francisco, Seattle, Shanghai, and Washington, DC.

Political Donations
$500
2008
$500
2003

Former Senator from Massachusetts

Transactions
Details Hidden

Extreme Networks, Inc. purchases Aerohive Networks, Inc.

Details Hidden

Merck & Co., Inc. purchases Peloton Therapeutics, Inc. from Topspin Management LLC, Nextech Invest AG, OrbiMed Advisors Private Equity, The Column Group LLC, Tichenor Ventures LLC, Remeditex Ventures LLC

Details Hidden

HealthEquity, Inc. purchases WageWorks, Inc.

Awards & Honors
2012
Super Lawyers - Northern California Super Lawyers
Admitted to the California Bar
Admitted to the New York Bar
Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert T. Ishii. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert T. Ishii's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert T. Ishii.